Reducing risk of type 2 diabetes (T2D)
    54.
    发明公开
    Reducing risk of type 2 diabetes (T2D) 有权
    雷迪西斯·罗斯科斯·冯典型2型糖尿病(T2D)

    公开(公告)号:EP2460517A1

    公开(公告)日:2012-06-06

    申请号:EP11191294.5

    申请日:2007-04-27

    IPC分类号: A61K31/19 A61K31/60 A61P3/10

    CPC分类号: A61K31/19 A61K31/60

    摘要: This invention relates to methods for reducing chronic subacute inflammatory states associated with obesity and improve glycaemia, thereby preventing or delaying the development of type 2 diabetes (T2D) in obese subjects, or subjects with metabolic syndrome, using non-acetylated forms of salicylate, for example salsalate or trilisate.

    摘要翻译: 本发明涉及用于减少与肥胖相关的慢性亚急性炎性状态并改善糖尿病的方法,从而通过使用非乙酰化水杨酸盐形式来预防或延缓肥胖受试者或具有代谢综合征的受试者的2型糖尿病(T2D)的发展,用于 例如樟脑酸或苦味酸。

    RETINAL IMAGING SYSTEM
    58.
    发明公开
    RETINAL IMAGING SYSTEM 审中-公开
    视网膜演示系统

    公开(公告)号:EP1694194A2

    公开(公告)日:2006-08-30

    申请号:EP04813510.7

    申请日:2004-12-10

    IPC分类号: A61B3/00 A61B3/10

    CPC分类号: A61B3/12 A61B3/14

    摘要: A retinal imaging system (20) includes a light source (27) and optics (22, 35) which receive light from the light source and which transmit the light to produce a beam that is substantially convergent. The beam penetrates a lens of an eye (24) and diverges following penetration of the lens to illuminate an area of a retina (25) of the eye. An imaging device (70) receives a reflection of light from the retina.